Protective Effect of Sufentanil on Myocardial Ischemia-Reperfusion Injury in Rats by Inhibiting Endoplasmic Reticulum Stress

Objective. Sufentanil is the most common drug in clinical practice for the treatment of ischemic heart disease. This study is to investigate the protective mechanism of sufentanil on rat myocardial ischemia-reperfusion (I/R) injury. Methods. A rat I/R model was established by ligating the left anter...

Full description

Saved in:
Bibliographic Details
Published in:Computational and mathematical methods in medicine Vol. 2022; pp. 6267720 - 8
Main Authors: Qiu, Liuji, Zhong, Guochen, Hou, Zhiqi, Lin, Jiayin, Sun, Laibao
Format: Journal Article
Language:English
Published: United States Hindawi 20-03-2022
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Objective. Sufentanil is the most common drug in clinical practice for the treatment of ischemic heart disease. This study is to investigate the protective mechanism of sufentanil on rat myocardial ischemia-reperfusion (I/R) injury. Methods. A rat I/R model was established by ligating the left anterior descending coronary artery. A total of 24 SD male rats were enrolled and divided randomly into the control group, I/R group, sufentanil group (SUF; 3 μg/kg), and diltiazem group (DLZ; 20 mg/kg; positive control). The rat hearts were subjected to 30 min of ischemia followed by 120 min of reperfusion. Subsequently, hemodynamics, pathological changes of myocardial tissue, serum biochemical parameters, oxidative stress factors, the level of serum inducible nitric oxide synthases (iNOS), interleukin-6 (IL-6), and other bioactive factors were analyzed in the rats. Result. Compared with the I/R group, sufentanil significantly improved cardiac action, myocardial fiber, and cardiomyocyte morphology and reduced inflammatory cell infiltration in rats in the SUF group. And the level of creatine kinase isoenzyme (CK-MB), troponin (cTn), lactate dehydrogenase (LDH), malondialdehyde (MDA), iNOS, and IL-6 was significantly declined in the serum of SUF group, while the activities of glutathione peroxidase (GSH-Px) and superoxide dismutase (SOD) were significantly activated in the myocardial tissues. In addition, sufentanil also significantly decreased the protein expression of GRP78, CHOP, Caspase 12, and ATF6 in the myocardial tissue of the SUF group. Conclusion. Sufentanil has a significant protective activity on myocardial I/R injury in rats, the mechanism of which may be associated with the inhibition of endoplasmic reticulum stress and oxidative stress.
AbstractList Objective. Sufentanil is the most common drug in clinical practice for the treatment of ischemic heart disease. This study is to investigate the protective mechanism of sufentanil on rat myocardial ischemia-reperfusion (I/R) injury. Methods. A rat I/R model was established by ligating the left anterior descending coronary artery. A total of 24 SD male rats were enrolled and divided randomly into the control group, I/R group, sufentanil group (SUF; 3 μg/kg), and diltiazem group (DLZ; 20 mg/kg; positive control). The rat hearts were subjected to 30 min of ischemia followed by 120 min of reperfusion. Subsequently, hemodynamics, pathological changes of myocardial tissue, serum biochemical parameters, oxidative stress factors, the level of serum inducible nitric oxide synthases (iNOS), interleukin-6 (IL-6), and other bioactive factors were analyzed in the rats. Result. Compared with the I/R group, sufentanil significantly improved cardiac action, myocardial fiber, and cardiomyocyte morphology and reduced inflammatory cell infiltration in rats in the SUF group. And the level of creatine kinase isoenzyme (CK-MB), troponin (cTn), lactate dehydrogenase (LDH), malondialdehyde (MDA), iNOS, and IL-6 was significantly declined in the serum of SUF group, while the activities of glutathione peroxidase (GSH-Px) and superoxide dismutase (SOD) were significantly activated in the myocardial tissues. In addition, sufentanil also significantly decreased the protein expression of GRP78, CHOP, Caspase 12, and ATF6 in the myocardial tissue of the SUF group. Conclusion. Sufentanil has a significant protective activity on myocardial I/R injury in rats, the mechanism of which may be associated with the inhibition of endoplasmic reticulum stress and oxidative stress.
Sufentanil is the most common drug in clinical practice for the treatment of ischemic heart disease. This study is to investigate the protective mechanism of sufentanil on rat myocardial ischemia-reperfusion (I/R) injury. A rat I/R model was established by ligating the left anterior descending coronary artery. A total of 24 SD male rats were enrolled and divided randomly into the control group, I/R group, sufentanil group (SUF; 3  g/kg), and diltiazem group (DLZ; 20 mg/kg; positive control). The rat hearts were subjected to 30 min of ischemia followed by 120 min of reperfusion. Subsequently, hemodynamics, pathological changes of myocardial tissue, serum biochemical parameters, oxidative stress factors, the level of serum inducible nitric oxide synthases (iNOS), interleukin-6 (IL-6), and other bioactive factors were analyzed in the rats. Compared with the I/R group, sufentanil significantly improved cardiac action, myocardial fiber, and cardiomyocyte morphology and reduced inflammatory cell infiltration in rats in the SUF group. And the level of creatine kinase isoenzyme (CK-MB), troponin (cTn), lactate dehydrogenase (LDH), malondialdehyde (MDA), iNOS, and IL-6 was significantly declined in the serum of SUF group, while the activities of glutathione peroxidase (GSH-Px) and superoxide dismutase (SOD) were significantly activated in the myocardial tissues. In addition, sufentanil also significantly decreased the protein expression of GRP78, CHOP, Caspase 12, and ATF6 in the myocardial tissue of the SUF group. Sufentanil has a significant protective activity on myocardial I/R injury in rats, the mechanism of which may be associated with the inhibition of endoplasmic reticulum stress and oxidative stress.
ObjectiveSufentanil is the most common drug in clinical practice for the treatment of ischemic heart disease. This study is to investigate the protective mechanism of sufentanil on rat myocardial ischemia-reperfusion (I/R) injury. MethodsA rat I/R model was established by ligating the left anterior descending coronary artery. A total of 24 SD male rats were enrolled and divided randomly into the control group, I/R group, sufentanil group (SUF; 3 μg/kg), and diltiazem group (DLZ; 20 mg/kg; positive control). The rat hearts were subjected to 30 min of ischemia followed by 120 min of reperfusion. Subsequently, hemodynamics, pathological changes of myocardial tissue, serum biochemical parameters, oxidative stress factors, the level of serum inducible nitric oxide synthases (iNOS), interleukin-6 (IL-6), and other bioactive factors were analyzed in the rats. ResultCompared with the I/R group, sufentanil significantly improved cardiac action, myocardial fiber, and cardiomyocyte morphology and reduced inflammatory cell infiltration in rats in the SUF group. And the level of creatine kinase isoenzyme (CK-MB), troponin (cTn), lactate dehydrogenase (LDH), malondialdehyde (MDA), iNOS, and IL-6 was significantly declined in the serum of SUF group, while the activities of glutathione peroxidase (GSH-Px) and superoxide dismutase (SOD) were significantly activated in the myocardial tissues. In addition, sufentanil also significantly decreased the protein expression of GRP78, CHOP, Caspase 12, and ATF6 in the myocardial tissue of the SUF group. ConclusionSufentanil has a significant protective activity on myocardial I/R injury in rats, the mechanism of which may be associated with the inhibition of endoplasmic reticulum stress and oxidative stress.
Author Zhong, Guochen
Lin, Jiayin
Qiu, Liuji
Sun, Laibao
Hou, Zhiqi
AuthorAffiliation 2 Department of Anesthesiology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, China
1 Department of Anesthesiology, Huizhou Central People's Hospital, Huizhou, Guangdong 516001, China
AuthorAffiliation_xml – name: 1 Department of Anesthesiology, Huizhou Central People's Hospital, Huizhou, Guangdong 516001, China
– name: 2 Department of Anesthesiology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, China
Author_xml – sequence: 1
  givenname: Liuji
  surname: Qiu
  fullname: Qiu, Liuji
  organization: Department of AnesthesiologyHuizhou Central People’s HospitalHuizhouGuangdong 516001China
– sequence: 2
  givenname: Guochen
  surname: Zhong
  fullname: Zhong, Guochen
  organization: Department of AnesthesiologyHuizhou Central People’s HospitalHuizhouGuangdong 516001China
– sequence: 3
  givenname: Zhiqi
  surname: Hou
  fullname: Hou, Zhiqi
  organization: Department of AnesthesiologyHuizhou Central People’s HospitalHuizhouGuangdong 516001China
– sequence: 4
  givenname: Jiayin
  surname: Lin
  fullname: Lin, Jiayin
  organization: Department of AnesthesiologyHuizhou Central People’s HospitalHuizhouGuangdong 516001China
– sequence: 5
  givenname: Laibao
  orcidid: 0000-0003-3782-4700
  surname: Sun
  fullname: Sun, Laibao
  organization: Department of AnesthesiologyThe First Affiliated HospitalSun Yat-sen UniversityGuangzhouGuangdong 510080Chinasysu.edu.cn
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35356663$$D View this record in MEDLINE/PubMed
BookMark eNp9kc2LFDEQxYOsuB968yw5Ctpuku589EWQZdSBFWVWwVtIpys7WbqTMeleGdg_fjPMOOjFU4q8X72q4p2jkxADIPSSkneUcn7JCGOXggkpGXmCzqhsVCUkVSfHmvw8Rec53xHCqeT0GTqtec2FEPUZeviW4gR28veAF86VCkeHb2YHYTLBDzgG_GUbrUm9NwNeZruG0ZtqBRtIbs6-6MtwN6ct9gGvzJRxty0_a9_5yYdbvAh93Awmj97iFUzezsM84pspQc7P0VNnhgwvDu8F-vFx8f3qc3X99dPy6sN1ZRtGpqoFSXtnQQC0tCm7O2lr1rSKCCY7QxVxUnakq1ntnLKqyExZTlvGVWls6gv0fu-7mbsReltuS2bQm-RHk7Y6Gq__VYJf69t4r1XLFZGyGLw-GKT4a4Y86dFnC8NgAsQ5ayYarrhSZDfr7R61KeacwB3HUKJ3geldYPoQWMFf_b3aEf6TUAHe7IG1D7357f9v9wiDXaIu
CitedBy_id crossref_primary_10_5498_wjp_v14_i6_894
crossref_primary_10_1155_2023_9815360
crossref_primary_10_1134_S0022093023030122
crossref_primary_10_1155_2022_9630716
crossref_primary_10_14336_AD_2023_0823_4
crossref_primary_10_1007_s12033_024_01104_x
Cites_doi 10.1152/ajpheart.2001.280.5.H2313
10.1007/s12035-014-9033-x
10.21037/atm.2018.05.29
10.1007/s10753-020-01410-x
10.1152/ajpheart.00783.2002
10.1038/s41569-019-0218-x
10.1126/science.1209038
10.1371/journal.pone.0033491
10.1002/jcp.26848
10.1016/j.ejps.2011.02.005
10.1016/j.jacc.2015.02.032
10.1074/jbc.M701917200
10.1111/j.1399-6576.2011.02456.x
10.3390/molecules191016158
10.3892/ijmm.2019.4414
10.1146/annurev-pathol-012513-104649
10.1016/j.pharmthera.2011.11.004
10.1128/MCB.21.4.1249-1259.2001
10.1016/j.canlet.2008.07.005
10.1155/2019/6935147
10.1016/j.bbadis.2020.165768
10.1007/s10616-017-0127-y
10.1590/1414-431X20175861
10.1016/j.ijcard.2016.03.176
10.1159/000485089
10.1097/FJC.0b013e31824a7b60
10.3892/etm.2013.900
10.1002/jat.3249
10.1080/08923970701812530
10.1186/s12871-017-0331-5
10.1016/0891-5849(96)00177-3
10.1111/jcmm.16691
10.3389/fimmu.2018.03083
10.18632/aging.202276
10.1053/jcan.2002.128415
10.1016/j.jare.2020.09.001
10.1016/j.jss.2012.05.081
10.1186/1479-5876-9-73
10.1016/S0254-6272(13)60106-5
10.5114/ceji.2014.45939
10.1002/cphy.c160006
ContentType Journal Article
Copyright Copyright © 2022 Liuji Qiu et al.
Copyright © 2022 Liuji Qiu et al. 2022
Copyright_xml – notice: Copyright © 2022 Liuji Qiu et al.
– notice: Copyright © 2022 Liuji Qiu et al. 2022
DBID RHU
RHW
RHX
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOI 10.1155/2022/6267720
DatabaseName Hindawi Publishing Complete
Hindawi Publishing Subscription Journals
Open Access Journals (Hindawi Publishing)
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1748-6718
Editor Khalaf, Osamah Ibrahim
Editor_xml – sequence: 1
  givenname: Osamah Ibrahim
  surname: Khalaf
  fullname: Khalaf, Osamah Ibrahim
EndPage 8
ExternalDocumentID 10_1155_2022_6267720
35356663
Genre Retracted Publication
Journal Article
GroupedDBID ---
29F
2DF
3YN
4.4
53G
5GY
5VS
6J9
AAFWJ
AAJEY
ABDBF
ACGFO
ACIPV
ACIWK
ADBBV
ADRAZ
AENEX
AFKVX
AHMBA
AIAGR
AJWEG
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CAG
CS3
DIK
EAD
EAP
EAS
EBC
EBD
EBS
EMK
EMOBN
EPL
EST
ESX
F5P
GROUPED_DOAJ
GX1
HYE
IAO
IEA
IHR
INH
INR
ITC
J.P
J9A
KQ8
M48
M4Z
ML~
O5R
OK1
P2P
REM
RHU
RHW
RHX
RNS
RPM
SV3
TFW
TUS
TWF
24P
3V.
7X7
88E
8FE
8FG
8FI
8FJ
ABJCF
ABUWG
AFKRA
AWYRJ
BENPR
BGLVJ
BPHCQ
BVXVI
CCPQU
CGR
COF
CUY
CVF
ECM
EIF
EJD
FYUFA
H13
HCIFZ
HF~
HMCUK
IPNFZ
L6V
M1P
M7S
NPM
O5S
PGMZT
PQQKQ
PROAC
PSQYO
PTHSS
RIG
UKHRP
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c420t-9e71dfce6ee914353f7c324980627ba180f77b0b323ff8c8f7c28c5192581df43
IEDL.DBID RPM
ISSN 1748-670X
IngestDate Tue Sep 17 21:13:21 EDT 2024
Fri Oct 25 08:39:17 EDT 2024
Thu Nov 21 21:49:32 EST 2024
Sat Sep 28 08:11:09 EDT 2024
Sun Jun 02 18:52:46 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
License This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright © 2022 Liuji Qiu et al.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c420t-9e71dfce6ee914353f7c324980627ba180f77b0b323ff8c8f7c28c5192581df43
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Correction/Retraction-3
Academic Editor: Osamah Ibrahim Khalaf
ORCID 0000-0003-3782-4700
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958077/
PMID 35356663
PQID 2645858804
PQPubID 23479
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8958077
proquest_miscellaneous_2645858804
crossref_primary_10_1155_2022_6267720
pubmed_primary_35356663
hindawi_primary_10_1155_2022_6267720
PublicationCentury 2000
PublicationDate 2022-03-20
PublicationDateYYYYMMDD 2022-03-20
PublicationDate_xml – month: 03
  year: 2022
  text: 2022-03-20
  day: 20
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Computational and mathematical methods in medicine
PublicationTitleAlternate Comput Math Methods Med
PublicationYear 2022
Publisher Hindawi
Publisher_xml – name: Hindawi
References 37416180 - Comput Math Methods Med. 2023 Jun 28;2023:9815360
22
44
23
45
25
26
27
C. Wang (30) 2013; 29
28
M. B. Khosravi (24) 2019; 14
K. D. McCullough (9) 2001; 21
W. Quan (19) 2013; 33
31
L. He (39) 2017; 44
10
32
12
34
35
14
36
15
16
38
17
18
A. A. Nassiri (29) 2012; 6
L. D. Horwitz (37) 1996; 21
1
K. Gerlach (13) 2002; 16
2
3
E. Hochhauser (42) 2003; 284
4
Z. Chen (40) 2001; 280
J. Wu (33) 2018; 10
6
7
8
L. G. Hu (11) 2013; 5
E. Robin (5) 2007; 282
41
20
21
43
References_xml – volume: 280
  start-page: H2313
  issue: 5
  year: 2001
  ident: 40
  article-title: Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice
  publication-title: American Journal of Physiology. Heart and Circulatory Physiology
  doi: 10.1152/ajpheart.2001.280.5.H2313
  contributor:
    fullname: Z. Chen
– ident: 34
  doi: 10.1007/s12035-014-9033-x
– ident: 2
  doi: 10.21037/atm.2018.05.29
– ident: 18
  doi: 10.1007/s10753-020-01410-x
– volume: 10
  start-page: 1109
  issue: 4
  year: 2018
  ident: 33
  article-title: Osthole attenuates myocardial ischemia/reperfusion injury in rats by inhibiting apoptosis and inflammation
  publication-title: American Journal of Translational Research
  contributor:
    fullname: J. Wu
– volume: 284
  start-page: H2351
  issue: 6
  year: 2003
  ident: 42
  article-title: Bax ablation protects against myocardial ischemia-reperfusion injury in transgenic mice
  publication-title: American Journal of Physiology. Heart and Circulatory Physiology
  doi: 10.1152/ajpheart.00783.2002
  contributor:
    fullname: E. Hochhauser
– ident: 1
  doi: 10.1038/s41569-019-0218-x
– ident: 7
  doi: 10.1126/science.1209038
– ident: 25
  doi: 10.1371/journal.pone.0033491
– ident: 3
  doi: 10.1002/jcp.26848
– ident: 41
  doi: 10.1016/j.ejps.2011.02.005
– ident: 23
  doi: 10.1016/j.jacc.2015.02.032
– volume: 282
  start-page: 19133
  issue: 26
  year: 2007
  ident: 5
  article-title: Oxidant stress during simulated ischemia primes cardiomyocytes for cell death during reperfusion
  publication-title: The Journal of Biological Chemistry
  doi: 10.1074/jbc.M701917200
  contributor:
    fullname: E. Robin
– ident: 14
  doi: 10.1111/j.1399-6576.2011.02456.x
– ident: 28
  doi: 10.3390/molecules191016158
– ident: 17
  doi: 10.3892/ijmm.2019.4414
– ident: 8
  doi: 10.1146/annurev-pathol-012513-104649
– ident: 38
  doi: 10.1016/j.pharmthera.2011.11.004
– volume: 21
  start-page: 1249
  issue: 4
  year: 2001
  ident: 9
  article-title: Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state
  publication-title: Molecular and Cellular Biology
  doi: 10.1128/MCB.21.4.1249-1259.2001
  contributor:
    fullname: K. D. McCullough
– ident: 10
  doi: 10.1016/j.canlet.2008.07.005
– ident: 4
  doi: 10.1155/2019/6935147
– ident: 35
  doi: 10.1016/j.bbadis.2020.165768
– ident: 16
  doi: 10.1007/s10616-017-0127-y
– ident: 27
  doi: 10.1590/1414-431X20175861
– volume: 6
  start-page: 203
  issue: 3
  year: 2012
  ident: 29
  article-title: Differences in cardiovascular disease risk factors associated with maximum and mean carotid intima-media thickness among hemodialysis patients
  publication-title: Iranian Journal of Kidney Diseases
  contributor:
    fullname: A. A. Nassiri
– ident: 6
  doi: 10.1016/j.ijcard.2016.03.176
– volume: 44
  start-page: 532
  issue: 2
  year: 2017
  ident: 39
  article-title: Antioxidants maintain cellular redox homeostasis by elimination of reactive oxygen species
  publication-title: Cellular Physiology and Biochemistry
  doi: 10.1159/000485089
  contributor:
    fullname: L. He
– ident: 43
  doi: 10.1097/FJC.0b013e31824a7b60
– volume: 5
  start-page: 807
  issue: 3
  year: 2013
  ident: 11
  article-title: Effects of different doses of sufentanil and remifentanil combined with propofol in target-controlled infusion on stress reaction in elderly patients
  publication-title: Experimental and Therapeutic Medicine
  doi: 10.3892/etm.2013.900
  contributor:
    fullname: L. G. Hu
– volume: 29
  start-page: 20
  issue: 1
  year: 2013
  ident: 30
  article-title: Panax quinquefolium saponins protect rat myocardium from ischemia/reperfusion injure through attenuating excessive endoplasmic reticulum stress
  publication-title: Chinese Journal of Pathophysiology
  contributor:
    fullname: C. Wang
– ident: 31
  doi: 10.1002/jat.3249
– ident: 45
  doi: 10.1080/08923970701812530
– ident: 26
  doi: 10.1186/s12871-017-0331-5
– volume: 14
  start-page: 177
  issue: 4
  year: 2019
  ident: 24
  article-title: Effect of the aortic root infusion of sufentanil on ischemia-reperfusion injury in patients undergoing coronary artery bypass grafting: a randomized clinical trial
  publication-title: The Journal of Tehran Heart Center
  contributor:
    fullname: M. B. Khosravi
– volume: 21
  start-page: 743
  issue: 6
  year: 1996
  ident: 37
  article-title: Efficacy of lipid soluble, membrane-protective agents against hydrogen peroxide cytotoxicity in cardiac myocytes
  publication-title: Free Radical Biology & Medicine
  doi: 10.1016/0891-5849(96)00177-3
  contributor:
    fullname: L. D. Horwitz
– ident: 20
  doi: 10.1111/jcmm.16691
– ident: 44
  doi: 10.3389/fimmu.2018.03083
– ident: 22
  doi: 10.18632/aging.202276
– volume: 16
  start-page: 703
  issue: 6
  year: 2002
  ident: 13
  article-title: Remifentanil-clonidine-propofol versus sufentanil-propofol anesthesia for coronary artery bypass surgery
  publication-title: Journal of Cardiothoracic and Vascular Anesthesia
  doi: 10.1053/jcan.2002.128415
  contributor:
    fullname: K. Gerlach
– ident: 21
  doi: 10.1016/j.jare.2020.09.001
– ident: 15
  doi: 10.1016/j.jss.2012.05.081
– ident: 32
  doi: 10.1186/1479-5876-9-73
– volume: 33
  start-page: 85
  issue: 1
  year: 2013
  ident: 19
  article-title: Antioxidant properties of magnesium lithospermate B contribute to the cardioprotection against myocardial ischemia/reperfusion injury in vivo and in vitro
  publication-title: Journal of Traditional Chinese Medicine
  doi: 10.1016/S0254-6272(13)60106-5
  contributor:
    fullname: W. Quan
– ident: 12
  doi: 10.5114/ceji.2014.45939
– ident: 36
  doi: 10.1002/cphy.c160006
SSID ssj0051751
Score 2.327875
SecondaryResourceType retracted_publication
Snippet Objective. Sufentanil is the most common drug in clinical practice for the treatment of ischemic heart disease. This study is to investigate the protective...
Sufentanil is the most common drug in clinical practice for the treatment of ischemic heart disease. This study is to investigate the protective mechanism of...
ObjectiveSufentanil is the most common drug in clinical practice for the treatment of ischemic heart disease. This study is to investigate the protective...
SourceID pubmedcentral
proquest
crossref
pubmed
hindawi
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 6267720
SubjectTerms Animals
Endoplasmic Reticulum Stress
Humans
Male
Malondialdehyde
Myocardial Reperfusion Injury - drug therapy
Myocardial Reperfusion Injury - metabolism
Myocardial Reperfusion Injury - prevention & control
Myocardium - pathology
Rats
Sufentanil - metabolism
Sufentanil - pharmacology
Sufentanil - therapeutic use
Title Protective Effect of Sufentanil on Myocardial Ischemia-Reperfusion Injury in Rats by Inhibiting Endoplasmic Reticulum Stress
URI https://dx.doi.org/10.1155/2022/6267720
https://www.ncbi.nlm.nih.gov/pubmed/35356663
https://search.proquest.com/docview/2645858804
https://pubmed.ncbi.nlm.nih.gov/PMC8958077
Volume 2022
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fa9swED6WwsZextr9yrYWDbpHNY5sRfLj6FLWh4zSbNA3YykSUUnk0MSMwv743flHWcZgsFdLNrburPtO-u4TwKkrx-S2jufWO57lmeHlRFhuPEmXlAKTrubohLn6eqM_T0kmR_a1MA1p35pwFlfrsxiWDbdys7ajnic2upqd61zqRKnRAAaIDfsUvZ1-JcbDcVsFqflEJTc9211KSvTFCBE8Iko6AS6VKYKZSboXkh4vKRf-Ef6GOP8kTv4WiS6ew7MOQrJP7asewiMXj-DJrNskfwE_r1rtBZzHWCtOzCrP5rUnmngMK1ZFNrvHGEa-sWKXmN-6dSg5YnF352taPmOX8RYHm4XIrsvdlpl7vLIMJhBJmk3jotog6l4Hy67drl1BZPOm6uQlfL-Yfjv_wrtDFrjNRLLjuVPjhbdu4lxO2Cn1yiLIyjXpF5tyrBOvlElMKlLvtdXYLLRF3CckQl2fpa_gIFbRvQFGyvyINqVKrcpM5ozKbaaME2XjEIshfOzHudi0WhpFk4NIWZBpis40QzjtjPCPbh96CxX4T9BGRxldVW8LBHmYBeHMlA3hdWuxhyf1Rh-C2rPlQwfS295vQTdsdLc7t3v733e-g6f0AURhE8l7ONjd1e4YBttFfdL48C8U5PU2
link.rule.ids 230,315,729,782,786,887,27933,27934,53800,53802
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFD6sHbu87L42u2rQPapxbCuSH0eX0rCmlKaDvhlLkYhGIocmZhT243eOL2UZg0FfLdsgviOd70ifPgEc2GJAYWt5ZpzlaZZqXgxjw7Uj65IixqKrvjphKs-u1NcR2eSI7ixMLdo32h-GxfIw-HmtrVwtTb_TifXPJ0cqEyqSsr8D93G8RlFXpDcTsMCMOGjOQSo-lNFVp3cXgkr9uI8cHjkl3QGXiATpzDDZSkoP5lQN__T_4px_Syf_yEXHT-_Yi2fwpCWf7EvT_Bzu2fACHk7a7fWX8Ou8cW3AGZA1tsasdGxaORKYB79gZWCTG8x-FFULNsbK2C59wZHF22tX0cIbG4cfCBPzgV0UmzXTN_hk7rUneTUbhVm5Qr6-9IZd2E2z9sim9XmVV_D9eHR5dMLb6xm4SeNowzMrBzNn7NDajFhX4qRBepYpcj7WxUBFTkod6SROnFNGYXOsDDLGWCBJdmnyGnZDGew-MPL0R54qZGJkqlOrZWZSqW1c1KE068HnDp981bhw5HX1IkROkOYtpD04aMH7z2ufOmRzHE20RVIEW1brHOkh1k84p6U92GuQvv1TFyw9kFsxcPsCOXVvtyD0tWN3C_WbO3_5ER6dXE5O89Px2be38Jg6Q0K4OHoHu5vryr6HnfWs-lCPg9_6oArZ
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1da9swFBVrx8peuu813ZcG3aNqR7Yj-XG0CQtbSmg26JuxZIloJHJoYkqhP773-iMsYzDYXi3ZIM6VdK58dC4hJybvY9galmprWJzGiuUDrpmyaF2Sc0i66tIJM3FxJc-HaJOzLfVVi_a1cqd-sTz1bl5rK1dLHXQ6sWA6OZNpIkMhglVhgz3yEOZsyLtEvVmEE9gV-81dSMkGIrzqNO9Jguk-D4DHA6_EOnBREgGlGUQ7G9OjOWbEN-5PvPN3-eQv-9HoyX-M5Ck5bEko_dx0eUYeGP-cHEza3-wvyN20cW-AlZA29sa0tHRWWRSae7egpaeTW9gFMboWdAwZslm6nAGbN9e2wgM4OvY_AS7qPL3MN2uqbuHJ3CmHMms69EW5At6-dJpemk1zBkln9b2Vl-THaPj97AtryzQwHfNww1Ij-oXVZmBMiuwrskIDTUslOiCrvC9DK4QKVcQja6WW0MylBubIEyDLNo5ekX1fenNEKHr7A19NRKRFrGKjRKpjoQzP65AqeuRTh1G2atw4sjqLSZIMYc1aWHvkpAXwL90-duhmMKvwV0nuTVmtM6CJkEfB2hb3yOsG7e2XuoDpEbETB9sO6Ni92wLw187dLdzH__zmB3IwPR9l38YXX9-QxzgW1MPx8C3Z31xX5h3ZWxfV-3oq3ANryw1Z
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Protective+Effect+of+Sufentanil+on+Myocardial+Ischemia-Reperfusion+Injury+in+Rats+by+Inhibiting+Endoplasmic+Reticulum+Stress&rft.jtitle=Computational+and+mathematical+methods+in+medicine&rft.au=Qiu%2C+Liuji&rft.au=Zhong%2C+Guochen&rft.au=Hou%2C+Zhiqi&rft.au=Lin%2C+Jiayin&rft.date=2022-03-20&rft.eissn=1748-6718&rft.volume=2022&rft.spage=6267720&rft.epage=6267720&rft_id=info:doi/10.1155%2F2022%2F6267720&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1748-670X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1748-670X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1748-670X&client=summon